Roughly 75% of the earth’s surface is covered by water, yet the ocean remains largely unexplored for drug discovery. Gloucester Marine Genomics Institute (GMGI) scientists are excited to lead the charge in exploring the ocean’s microbiome to provide research to inform treatments – possibly cures – of devastating diseases. Dr. Andrea Bodnar is here to talk about some of the latest marine research and its look at anti-ageing and human health effects.
Andrea Bodnar, Ph.D. is a Scientist whose research interests lie at the intersection of marine biology and human health. With experience in both academic and industry settings, she brings a unique perspective and broad experience important to establishing a new world-class research institute. Prior to joining GMGI as the Science Director, Andrea was a Senior Scientist in the Molecular Discovery Lab at the Bermuda Institute of Ocean Sciences (BIOS). At BIOS, her research program focused on using sea urchins as models to understand the cellular and molecular mechanisms underlying extreme longevity, negligible ageing and naturally occurring resistance to cancer. Prior to that, Andrea held Senior Scientist positions in the Oncology Department of Hoffman-La Roche, the Department of Cell Biology and Pharmacology at Geron Corporation and the Bioprocessing Technology Institute at the National University of Singapore. She received a BSc and PhD in Biochemistry from McMaster University in Canada and conducted post-doctoral studies in the Department of Neurological Science at the University of London.